Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP7KG
|
||||
Drug Name |
racemic-5-chloro-6-(1H-indol-3-yl)-2,2,4,8-tetramethyl-1,2,3,4-tetrahydroquinoline
|
||||
Synonyms |
CHEMBL404496
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C21H23ClN2
|
||||
Canonical SMILES |
CC1CC(C)(C)Nc2c(C)cc(c(Cl)c12)c3c[nH]c4ccccc34
|
||||
InChI |
InChI=1S/C21H23ClN2/c1-12-9-15(16-11-23-17-8-6-5-7-14(16)17)19(22)18-13(2)10-21(3,4)24-20(12)18/h5-9,11,13,23-24H,10H2,1-4H3
|
||||
InChIKey |
PFUXODWITQFWRK-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.